Swiss-listed HBM Healthcare (HBMN) may see a gain from its investment in the private Danish company Y-mAbs Therapeutics, which has filed an S1 registration to raise up to $92m in a Nasdaq IPO. HBM has an 8.2% shareholding in Y-mAbs, which it valued at CHF23m (1.9% of NAV) in its accounts – suggesting the company currently has a CHF280m […]
Biotech trust stock favourite Alnylam Pharmaceuticals (Nasdaq: ALNY) gained more than 16% yesterday after the presentation of ostensibly highly positive clinical trial data on one of its key competitors at a scientific meeting. Alnylam is held by several of the sector’s specialist investment trusts including Biotech Growth (BIOG, 3.6% of NAV) and BB Biotech (BBB, 3.6% of NAV) […]
BB-backed Ionis hit as FDA rejects Waylivra Shares in Ionis Pharmaceuticals (Nasdaq: IONS), a key shareholding for BB Biotech (10.9% of NAV) and several other specialist investment vehicles, fell by more than 12% after hours yesterday, after the FDA issued a complete response letter (CRL) – effectively a rejection – of its new drug application for Waylivra (volanesorsen). The […]
Standard Life UK Smaller Companies – outperformance, merger and lower fees – the NAV of Standard Life UK Smaller Companies (SLS) delivers a total return of 24.8%, compared with the total return of 8.5% of it’s reference index, the Numis Smaller Companies plus AIM (excluding Investment Companies) Index. Outperformance The company’s performance was good throughout the year in question with a particularly […]
Electra’s Formal Sales Process is closed – but the Strategic Review continues For sometime, Electra Private Equity (ELTA) has been conducting a strategic review on itself. The objective of the review has been to consider all options for the future direction of the company and to implement a strategy to optimise shareholder value. There had been two previous […]
Trust favourite Gilead gears up for filgotinib RA Phase III data Gilead Sciences, a widely held stock among biotech investment trusts and a top 10 holding for BB Biotech (BBB, 5.1% of NAV) and Biotech Growth Trust (BIOG, 3.9%), is expected to report top-line results from two trials involving its JAK 1 selective inhibitor filgotinib in rheumatoid arthritis (RA) and in ankylosing […]
WPCT takes profits on Autolus post IPO share price rise Woodford Patient Capital Trust (WPCT) appears to have taken some profits on its investment in the high-flying second generation CAR-T therapy company, Autolus Therapeutics, through a partial sale of its recently-boosted stake, according to an analysis of trust’s shareholdings in July reported this morning. This is […]
AbbVie exercises option for HBM-backed Argenx antibody Dutch/Belgian antibody company Argenx (Euronext & Nasdaq: ARGX), a top ten holding for Swiss-listed HBM Healthcare (HBMN, 2.6% of NAV) has disclosed that AbbVie has taken up its option to licence the preclinical stage immuno-oncology product ARGX-115. Argenx and AbbVie, a US based pharmaceutical major, entered into an option deal covering ARGX-115 in April […]
WPCT-backed Immunocore enters Phase I with lead GSK project Woodford Patient Capital Trust (WPCT)-backed Immunocore has started a Phase I study of IMCnyeso, the lead engineered T cell product under its collaboration with GlaxoSmithKline (GSK), for a range of cancers. The 63-patient Phase I/II study will assess ImmTAC in patients with non-small cell lung cancer (NSCLC), […]
Regional REIT adds eight offices to its portfolio Regional REIT (RGL) has announced that it has exchanged and completed on contracts to purchase eight assets for £31.4 million. (Update 24/08/2018) the acquisition was completed on 23rd August 2018. Regional diversification The portfolio is spread out from the Stockton-on-Tees in the North to High Wycombe in the South. […]
Please review our cookie, privacy & data protection and terms and conditions policies and, if you accept, please select your place of residence and whether you are a private or professional investor.
Due to data protection policies, USA residents can not access our data.
Your content has been curated